TITLE

Accutane: under attack

AUTHOR(S)
Kaplan, J.
PUB. DATE
January 1989
SOURCE
Vogue;Jan89, Vol. 179 Issue 1, p112
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Discusses the current controversy over the anti-acne drug Accutane. Its approval by the Food and Drug Administration; Warnings and advisories issued; The FDA's Dermatologic Drugs Advisory Committee recommendation; FDA's response; Arguments surrounding.
ACCESSION #
8901300512

 

Related Articles

  • New thinking on psoriasis. Young, Stephanie // Glamour;Apr93, Vol. 91 Issue 4, p48 

    Offers a look at psoriasis. Stress plays a major role in aggravating the condition for some people; Alcohol can set off psoriasis; Obesity and overeating may cause an outbreak; Better remedies for scalp psoriasis; New, more effective topical treatments; Details.

  • Cyclosporine for plaque-type psoriasis. Ellis, C.N.; Fradin, M.S. // New England Journal of Medicine;1/31/91, Vol. 324 Issue 5, p277 

    Reports the results of a 16-week, double-blind, dose-response trial in a single study center to determine the efficacy of three doses of cyclosporine in 85 patients with psoriasis. Background; Methods; Results; Conclusions.

  • The challenge of intracellular pathogens. Mahmoud, A.A.F. // New England Journal of Medicine;3/12/92, Vol. 326 Issue 11, p761 

    Editorial. Discusses the identification of several species and subspecies of leishmania. Studies that have examined the role of parasite surface molecules; Possible efficacy of allopurinol in the treatment of American cutaneous leishmaniasis; More.

  • Perifollicular pigmentation in bullous pemphigoid: A diagnostic sign. Kumaresan, M.; Srinivas, C. R. // Indian Dermatology Online Journal;2011, Vol. 2 Issue 1, p36 

    The article discusses the healing stage of bullous pemphigoid (BP), that shows the prominence of hair follicles appearing as tiny raised papules over raw areas followed by follicular pigmentation, as well as intense postinflammatory pigmentation.

  • Verrucous Carcinoma. Conologue, Theresa Dressler; Lim, Scott; McCollough, Martha // American Family Physician;12/1/2001, Vol. 64 Issue 11, p1808 

    Presents a case report of an old woman with a verrucous carcinoma on her left upper back. Description of the skin disease; Factors which cause verrucous carcinoma; Treatment for the disease.

  • Fact Box.  // Current Health 2;Oct2002, Vol. 29 Issue 2, SKIN SMARTS: A TEEN'S... p4 

    Focuses on the role of a dermatologist in treating a wide variety of medical, surgical and cosmetic problems. List of symptoms needing a dermatologist's attention; Importance of early treatment; Prevention of serious dermatological condition.

  • New warning about Accutane and birth defects. Willis, J. // FDA Consumer;Oct88, Vol. 22 Issue 8, p26 

    In the wake of new reports of birth defects in babies whose mothers took the acne drug Accutane, the US Food and Drug Administration (FDA) and the drug maker, Hoffmann La Roche, are using bolder warnings against using the drug during pregna ncy. Restrictions; Label warnings; Effects of Accutane.

  • Recent Developments in Receptor-Selective Retinoids. Nagpal, Sunil; Chandraratna, Roshantha A.S. // Current Pharmaceutical Design;Jun2000, Vol. 6 Issue 9, p919 

    Natural (all trans-retinoic acid, RA) and synthetic retinoids exhibit potent anti-proliferative, normalization of differentiation and anti-inflammatory activities which appear to account for their therapeutic effects in acne, psoriasis, photoaging, precancerous lesions and established cancers....

  • Cutaneous disorders: When all else fails, look for infection.  // Modern Medicine;Sep94, Vol. 62 Issue 9, p23 

    Reports on the utilization of antibiotic approach in the treatment of cutaneous disorders in the United States. Granuloma alopecia; Psoriasis; Rosacea.

  • Mechanism of action of antipruritic drugs. Krause, Lionel; Shuster, Sam // British Medical Journal (Clinical Research Edition);10/22/1983, Vol. 287 Issue 6400, p1199 

    Examines the mechanisms of antipruritic drugs. Activation of antipruritic drugs related to sedation; Condition for H[sub 1] receptor antagonists to have a peripheral antipruritic action; Measurement of scratching and other body movements.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics